Robert Nechanitzky | Senior Scientist
Zymeworks Inc | Canada

Robert Nechanitzky is a seasoned Senior Scientist at Zymeworks Inc., a leading biotechnology company specializing in the development of innovative biotherapeutics. With a strong background in molecular biology and immunology, Robert has played a pivotal role in advancing the company's research and development efforts on bi- and multispecific molecules for the treatment of AIID-related indications. 

Throughout his career, Robert has demonstrated a passion for pushing the boundaries of scientific discovery and translating cutting-edge research into tangible therapeutic solutions. His expertise lies in the design and optimization of novel protein and mRNA therapeutics, with a focus on autoimmunity and oncology.

Robert's collaborative approach and keen problem-solving skills have been instrumental in driving successful projects from concept to clinic. He is dedicated to leveraging his scientific acumen to address unmet medical needs and improve patient outcomes.

At the Festival of Biologics USA 2026, Robert will share insights on the journey of discovering, developing, and bringing a bispecific molecule for the treatment of COPD and asthma to a Phase 1 clinical trial. His presentation will offer valuable insights into the challenges and opportunities in the biopharmaceutical industry, as well as the critical role of innovation in driving progress toward novel therapies. 

With a track record of scientific excellence and a commitment to advancing the field of biologics, Robert Nechanitzky is a respected leader in the biotechnology community. His expertise and contributions continue to make a significant impact on the development of transformative biotherapeutics.